Patterson Sandra 4
4 · GILEAD SCIENCES, INC. · Filed Mar 12, 2025
Insider Transaction Report
Form 4
Patterson Sandra
SVP, Controllership
Transactions
- Exercise/Conversion
Common Stock
2025-03-10+1,952→ 40,077 total - Tax Payment
Common Stock
2025-03-10$117.21/sh−624$73,139→ 39,453 total - Exercise/Conversion
Restricted Stock Unit
2025-03-10−1,952→ 9,875 total→ Common Stock (1,952 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
- [F2]Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
- [F3]The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.